Upcoming Webinars Archived Webinars Training Vitals Host A Webinar About Get Updates Contact

Mechanism Behind Tumor Growth And Metastasis Revealed

XTALKS VITALS NEWS

In the early stages of tumor formation, TGF-beta acts as an inhibitory compound by preventing cell division and inducing cell death.

Tweetables from this article:

Tweet: "Only now have researchers identified some of the mechanisms responsible for TGF-beta’s switch"

Share this!

September 9, 2016 | by Sarah Massey, M.Sc.

While previous research has found that transforming growth factor beta (TGF-beta) can both stimulate and suppress cancerous tumor growth and development, the mechanisms behind this were unknown. Now, researchers at Ludwig Institute for Cancer Research at Uppsala University have uncovered some of the details governing this process.

The Ludwig Institute for Cancer Research at Uppsala University has a 30-year history in the study of TGF-beta’s role in cell signaling and tumorigenesis. Only now have researchers identified some of the mechanisms responsible for TGF-beta’s switch from tumor suppression to tumor enhancing.

“Our hope is that these findings will make it possible to discover a way to selectively inhibit the TGF-beta signals that stimulate tumor development without knocking out the signals that inhibit tumor development, and that this can eventually be used in the fight against cancer,” said Eleftheria Vasilaki, postdoctoral researcher at Uppsala University. The results of the research were published in the journal, Science Signaling.



TGF-beta is most active during fetal development where it acts to regulate cell growth and differentiation. The cytokine also plays a complicated role when it comes to tumor growth and development.

In collaboration with a research team in Japan, Vasilaki and colleagues found that TGF-beta works alongside another oncoprotein, Ras, which is often overexpressed in cancer cells. The two proteins suppress p53 protein, which is a key regulator of tumor development.

The suppression of p53 works to enhance the effect of a related protein, delta-Np63, which acts to stimulate cancer development and tumor metastasis. These findings could provide researchers with a better understanding of tumorigenesis, and TGF-beta could become a valuable drug target for the development of cancer therapies.


Keywords: Tumor Growth, Cancer Research, Metastasis


| NEXT ARTICLE | MORE NEWS | BLOGS | VIDEOS | POLLS & QUIZZES | WEBINARS |

Share this with your colleagues!

MORE NEWS
Better Meal Planning for Diabetics Using a Predictive Blood Sugar App

April 21, 2017 - A new app could allow people with type 2 diabetes to make predictions about the impact of a meal on their blood sugar levels, before they even take a bite.

Featured In: Life Science News


Bacterial Biomarkers Could Make Diagnosing Colorectal Cancer Less Invasive

April 20, 2017 - Researchers at The University of Texas Health Science Center at Houston School of Public Health have identified specific strains of gut bacteria which have been associated with colorectal cancer.

Featured In: Life Science News


Weetabix Cereal Sold to Post in £1.4 Billion Deal

April 20, 2017 - The cereal was sold by Shanghai-based Bright Food, which acquired a controlling stake in the company in 2012.

Featured In: Food News

LEAVE A COMMENT
 
  
THE XTALKS VITALS LIFE SCIENCE BLOG

What Medical Device Manufacturers Need to Know Before Developing a Biological Safety Evaluation

REGISTER FOR THESE WEBINARS

Electronic Informed Consent: 2017 Industry Survey Results


Critical CRO Oversight Metrics: How to Establish the Right Metrics and Monitor them in Real-Time


The Modernization of eCOA Technology for Clinical Trials


Developing a Biological Safety Evaluation


Copyright © 2016-2017 Honeycomb Worldwide Inc.